Biote Aktie - BTMD

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

6,20

Gebot

5,85

Fragen

8,21

Volumen

110.301

6,025 Tagesbereich 6,30

3,6538 52-Wochen-Bereich 8,44

Marktkapitalisierung

336,89M

Handelsende

6,03

Handelsbeginn

6,1178

Letzte Trade

6.51

Letzter Handelszeitpunkt

Finanzvolumen

US$ 682.886

VWAP

6,1911

Durchschnittliches Volumen (3 Mio.)

145.343

Ausgegebene Aktien

54.337.138

Dividendenrendite

Kurs-Gewinn-Verhältnis

101,31

Gewinn pro Aktie (EPS)

0,06

Erlöse

185,36M

Nettogewinn

3,32M

Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business.

Sektor

Medicinal Chems,botanicl Pds

Branche

Medicinal Chems,botanicl Pds

Website

www.biote.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Biote Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker BTMD. The last closing price for Biote was US$6,03. Over the last year, Biote shares have traded in a share price range of US$ 3,6538 to US$ 8,44.

Biote currently has 54.337.138 shares in issue. The market capitalisation of Biote is US$327,65 million. Biote has a price to earnings ratio (PE ratio) of 101.31.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Biote Reports Third Quarter 2024 Financial Results

Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages Biote...

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Second Quarter 2024 Financial Results

Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance Biote (NASDAQ: BTMD), a leading solutions...

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports First Quarter 2024 Financial Results

Procedure revenue growth and strengthened profitability drive solid financial performance Phased launch of BioteRx remains on track Reaffirms 2024 financial guidance, with an acceleration in...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.01	-0.161030595813	6.21	6.36	5.7582	93143	6.07097617	CS
4	-0.26	-4.02476780186	6.46	6.9	5.68	123030	6.2535923	CS
12	1.04	20.1550387597	5.16	6.98	5.005	145343	6.01126539	CS
26	-1.45	-18.954248366	7.65	8.44	4.935	171345	6.32744284	CS
52	1.5	31.914893617	4.7	8.44	3.6538	162685	6.19864287	CS
156	-3.84	-38.2470119522	10.04	10.51	2.75	123969	5.71835481	CS
260	-3.84	-38.2470119522	10.04	10.51	2.75	123969	5.71835481	CS

BTMD - Frequently Asked Questions (FAQ)

What is the current Biote share price?

The current share price of Biote is US$ 6,20

How many Biote shares are in issue?

Biote has 54.337.138 shares in issue

What is the market cap of Biote?

The market capitalisation of Biote is USD 327,65M

What is the 1 year trading range for Biote share price?

Biote has traded in the range of US$ 3,6538 to US$ 8,44 during the past year

What is the PE ratio of Biote?

The price to earnings ratio of Biote is 101,31

What is the cash to sales ratio of Biote?

The cash to sales ratio of Biote is 1,81

What is the reporting currency for Biote?

Biote reports financial results in USD

What is the latest annual turnover for Biote?

The latest annual turnover of Biote is USD 185,36M

What is the latest annual profit for Biote?

The latest annual profit of Biote is USD 3,32M

What is the registered address of Biote?

The registered address for Biote is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Biote website address?

The website address for Biote is www.biote.com

Which industry sector does Biote operate in?

Biote operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	260,93M
NITON2OFF Inc	US$ 2,6306 (145,85%)	358,28M
CRNCCerence Inc	US$ 19,33 (143,76%)	161,8M
KITTNauticus Robotics Inc	US$ 3,8249 (140,56%)	104,8M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,64M
HWHHWH International Inc	US$ 0,4621 (-28,80%)	7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5,69 (-26,30%)	24,77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5,59 (-23,42%)	161,15k
PTLEPTL Ltd	US$ 9,35 (-23,30%)	1,04M
NXUNXU Inc	US$ 0,725868 (-22,78%)	7,59M
NITON2OFF Inc	US$ 2,6306 (145,85%)	358,28M
TGLTreasure Global Inc	US$ 0,382 (101,58%)	337,5M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,64M
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	260,93M
NVDANVIDIA Corporation	US$ 144,47 (4,45%)	230,01M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Biote Corporation (BTMD) Börsenkurse

Biote Corporation (BTMD)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Biote Corporation

BTMD Neueste Nachrichten

BTMD - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen